Literature DB >> 1294745

Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic.

J D Bradley1, K D Brandt, B P Katz, L A Kalasinski, S I Ryan.   

Abstract

Our randomized double blinded comparison of acetaminophen versus analgesic and antiinflammatory doses of ibuprofen in the treatment of 182 subjects with knee osteoarthritis (OA) systematically evaluated soft tissue tenderness and joint swelling. Improvement in these signs of joint inflammation was associated with lessening of disability (p = 0.02), and reduction in rest pain (p = 0.07), but not with the drug treatment regimen. Thus, joint tenderness and swelling, presumptive evidence of synovitis, may not be a priori indications for use of an antiinflammatory drug, or predict greater responsiveness to treatment with an antiinflammatory drug than to a pure analgesic, in symptomatic treatment of patients with knee OA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1294745

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  31 in total

Review 1.  Clinical assessment and significance of inflammation in knee osteoarthritis.

Authors:  V T Baddour; J D Bradley
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

Review 2.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).

Authors:  K M Jordan; N K Arden; M Doherty; B Bannwarth; J W J Bijlsma; P Dieppe; K Gunther; H Hauselmann; G Herrero-Beaumont; P Kaklamanis; S Lohmander; B Leeb; M Lequesne; B Mazieres; E Martin-Mola; K Pavelka; A Pendleton; L Punzi; U Serni; B Swoboda; G Verbruggen; I Zimmerman-Gorska; M Dougados
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

Review 3.  Pharmacotherapy for pain in rheumatologic conditions: the neuropathic component.

Authors:  Keri L Fakata; Arthur G Lipman
Journal:  Curr Pain Headache Rep       Date:  2003-06

4.  Key questions concerning paracetamol and NSAIDs for osteoarthritis.

Authors:  P Courtney; M Doherty
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

Review 5.  Anti-inflammatory agents for the treatment of musculoskeletal pain and arthritis.

Authors:  Keri L Fakata
Journal:  Curr Pain Headache Rep       Date:  2004-06

6.  Sonography for hip joint effusion in adults with hip pain.

Authors:  S M Bierma-Zeinstra; A M Bohnen; J A Verhaar; A Prins; A Z Ginai-Karamat; J S Laméris
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 7.  Acetaminophen for osteoarthritis.

Authors:  T E Towheed; L Maxwell; M G Judd; M Catton; M C Hochberg; G Wells
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

8.  North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-08-22

9.  Paracetamol in osteoarthritis of the knee.

Authors:  C Miceli-Richard; M Le Bars; N Schmidely; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

Review 10.  Pharmacokinetic optimisation of the treatment of osteoarthritis.

Authors:  K J Skeith; D R Brocks
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.